Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), remains a poorly defined and under-researched condition affecting millions globally. Despite its prevalence, […]
Systemic Reluctance: Medical Inertia and the Pharmaceutical Industry’s Influence on Long COVID Treatment
Abstract Despite the global burden of Long COVID, the medical profession has demonstrated a striking reluctance to engage in consistent diagnosis, treatment, and research. This article explores the multifactorial roots […]
Data-driven RECOVER research produces new discoveries about Long COVID.
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person […]
Data-driven RECOVER research produces new discoveries about Long COVID.
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person […]
🧪 What Long-Term Safety Studies Are Still Needed for COVID Vaccines?
Despite billions of doses administered, some areas remain under-researched: 🔹 Obstetric and Reproductive Health 🔹 Cancer Risk 🔹 Autoimmune and Neurological Conditions 📉 Limitations of Current Safety Models Critics argue […]
Pfizer COVID Vaccine Suggests Some People Got Highly Dangerous Shots, Others Got a Placebo
Danish scientists uncovered compelling evidence that a significant percentage of the batches of the Pfizer-BioNTech COVID-19 vaccine distributed in the EU likely consisted of placebos — and the non-placebo batches […]
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
By LAURAN NEERGAARD and MATTHEW PERRONE WASHINGTON (AP) — The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is sowing uncertainty about updates to other […]
Long COVID Now: A Special Report
Five years after the pandemic hit, questions remain about how and why millions of Americans are still struggling with long-term disease. Michele G. Sullivan, Health Central According to a June 2024 […]
An Explosion of ME/CFS in the US + The Real Difference RECOVER May Make In Long COVID
by Cort Johnson The Recover Initiative produced an important paper! So, it is possible… 🙂 That’s a bit tongue-in-cheek. As RECOVER has started to move out of its electronic health care studies – […]
Data-driven RECOVER research produces new discoveries about Long COVID.
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person […]